By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Wilson Therapeutics 



  Stockholm    Sweden
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Wilson Therapeutics Presents Preliminary Clinical Data On Decuprate At The 20th International Congress Of Parkinson's Disease And Movement Disorders 6/23/2016 11:03:55 AM
Wilson Therapeutics Presents Preliminary Clinical Data On Decuprate At The 20th International Congress Of Parkinson´s Disease And Movement Disorders 6/23/2016 7:32:29 AM
Wilson Therapeutics Appoints Erik Penser As Liquidity Provider 6/16/2016 8:05:18 AM
Wilson Therapeutics Appoints Rick Lilley As Chief Regulatory Officer 6/16/2016 8:03:53 AM
Wilson Therapeutics: Change In Number Of Shares In Wilson Therapeutics 5/31/2016 1:20:47 PM
Wilson Therapeutics Presents Encouraging Clinical Data On Decuprate At The Congress Of The European Academy Of Neurology 5/31/2016 11:21:59 AM
Wilson Therapeutics Interim Report January 1 – March 31, 2016 5/19/2016 1:11:08 PM
Wilson Therapeutics Interim Report January 1 – March 31, 2016 5/19/2016 12:06:36 PM
Wilson Therapeutics Announces That the Ongoing Phase II Study Has Been Fully Enrolled 5/18/2016 10:32:18 AM
Wilson Therapeutics Presents Data On Decuprate (WTX101) From Ongoing Phase 2 Study At The International Liver Congress 2016 4/14/2016 10:48:09 AM
12
//-->